Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Marker for Illness and Disease

By HospiMedica staff writers
Posted on 12 Aug 2004
A condition called metabolic syndrome has been found to be closely linked to breast and prostate cancer as well as diabetes, cardiovascular disease, chronic liver disease, and sleep apnea. More...


Diagnosing the condition so that treatment could begin would greatly help to reduce the incidence of illness and disease, since the condition affects more than 25% of all people in the United States. Diagnosis is fairly simple, since those people at risk will have three of the following traits: waist measurement of 40 inches or more among men and 35 inches or more among women, blood triglyceride levels of 150 or greater, blood pressure of 130/83 or higher, and fasting blood sugar of 100 or more. The incidence of metabolic syndrome appears to be higher among people of lower socioeconomic status. Treatment consists mainly of lifestyle changes, such as a vigorous physical fitness program and good nutrition, according to the authors.

The incidence of heart risk associated with metabolic syndrome could be reduced by as much as 10%, and the incidence of diabetes could be reduced by as much as 35%, according to the study conducted by Earl S. Ford, M.D., MPH, of the (U.S.) National Center for Chronic Disease Prevention and Control (Atlanta, GA, USA).

A second study was conducted by Gerald Reaven, M.D., of Stanford University (Palo Alto, CA, USA), who was the first to identify metabolic syndrome. According to Dr. Reaven, the condition also leads to hypertension. His report concludes that a person who is more physically fit will produce appropriate levels of insulin and be less likely to develop metabolic syndrome.

Both studies were presented at the annual meeting of the American Association of Clinical Chemistry in Los Angeles (CA, USA) in July 2004.




Related Links:
National Center for Chronic Disease
Stanford U.

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.